GlassScriptPhysician profile
Timothy T Coyle
NPI 1952376964
$2,004.17
in general payments reported to CMS, 2019-2025
7 companies · $716 in 2025
The $716 reported for 2025 was more than what 82% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $121 · 2021: $102 · 2022: $68.17 · 2023: $426 · 2024: $337 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705 · Travel and Lodging: $468 · Education: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.57 |
| Travel and Lodging | $468.32 |
| Education | $306.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,266.42 | 2023-2025 | |
| Dentsply Sirona INC | $325.88 | 2019-2025 | Implant Dentistry, Astra Tech Implant System |
| Nobel Biocare USA | $176.61 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $139.57 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $58.41 | 2019-2020 | |
| Astellas Pharma US INC | $22.21 | 2020 | |
| Dentsply Ih INC. | $15.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.